ArticleContemporary oncology (Poznan, Poland)2021
Validation of the dosimetric and geometric accuracy of MR-only treatment planning solution for prostate cancer radiotherapy.
Article in Contemporary oncology (Poznan, Poland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 3 citations in OpenAlex.
- Metal artifact reduction for 3 T MRI-only prostate radiotherapy in patients with hip prostheses: impact on target definition, synthetic CT generation, dose calculation, and fiducial marker identification.Radiation oncology (London, England) · 2026Article
- A Pilot Study of PSMA PET/CT and MRI Fusion for Prostate Cancer: Software to Replace PET/MRI Hardware.Journal of clinical medicine · 2024Article
- Prostate volume analysis in image registration for prostate cancer care: a verification study.Physical and engineering sciences in medicine · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe aim was to validate the dosimetric and geometric accuracy of radiotherapy treatment plans for prostate cancer based on magnetic resonance (MR) imaging only and a solution based on computed tomography (CT) supported by MR imaging. MATERIAL AND
methodsWe used CT and MR images of ten prostate cancer patients implanted with three fiducial markers (FM) in the prostate gland. Rigid registration based on FM was performed to assess the fusion accuracy between MR and CT images. The differences between prostate contours (clinical target volume - CTV) on CT (CTV
resultsThe averaged fiducial registration error was equal to 0.5 mm. All CTV
conclusionsMR imaging allows for a more precise delineation of the prostate compared to CT imaging. The workflow of plan preparation based on MR and CT is burdened with an FM registration error that is eliminated by an MR-only solution with no compromise on dose distribution.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.